TGA Approval

APO-RIVASTIGMINE PATCH 15 rivastigmine 13.3 mg/24 hours transdermal drug delivery system sachet (273559)

ARTG ID

273559

ARTG Name

APO-RIVASTIGMINE PATCH 15 rivastigmine 13.3 mg/24 hours transdermal drug delivery system sachet

Sponsor

Arrotex Pharmaceuticals Pty Ltd

ARTG Date

January 25, 2017

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Arrotex Pharmaceuticals Pty Ltd.

Ingredient Name

rivastigmine

Empowering clinical research with data-driven insights and AI-powered tools.

APO-RIVASTIGMINE PATCH 15 rivastigmine 13.3 mg/24 hours transdermal drug delivery system sachet (273559) - TGA 批准文号 | MedPath